NL7212915A - - Google Patents

Info

Publication number
NL7212915A
NL7212915A NL7212915A NL7212915A NL7212915A NL 7212915 A NL7212915 A NL 7212915A NL 7212915 A NL7212915 A NL 7212915A NL 7212915 A NL7212915 A NL 7212915A NL 7212915 A NL7212915 A NL 7212915A
Authority
NL
Netherlands
Application number
NL7212915A
Other versions
NL176458C (nl
NL176458B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NLAANVRAGE7212915,A priority Critical patent/NL176458C/nl
Priority to ZA737131*A priority patent/ZA737131B/xx
Priority to IE1587/73A priority patent/IE38221B1/xx
Priority to US396251A priority patent/US3892695A/en
Priority to AU60197/73A priority patent/AU472312B2/en
Priority to GB4331873A priority patent/GB1445765A/en
Priority to DK507673AA priority patent/DK140668B/da
Priority to CA181,312A priority patent/CA1019733A/en
Priority to AR250175A priority patent/AR203090A1/es
Priority to FR7333768A priority patent/FR2199996B1/fr
Priority to HUAO373A priority patent/HU167206B/hu
Priority to CH1358173A priority patent/CH592094A5/xx
Priority to BE135926A priority patent/BE805178A/xx
Priority to FI2963/73A priority patent/FI54311C/fi
Priority to JP48106809A priority patent/JPS5912678B2/ja
Priority to DE2347727A priority patent/DE2347727C2/de
Priority to SE7312873A priority patent/SE407686B/sv
Priority to ES418996A priority patent/ES418996A1/es
Publication of NL7212915A publication Critical patent/NL7212915A/xx
Publication of NL176458B publication Critical patent/NL176458B/nl
Application granted granted Critical
Publication of NL176458C publication Critical patent/NL176458C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NLAANVRAGE7212915,A 1972-09-23 1972-09-23 Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze voor de bereiding van daartoe geschikte actieve stoffen. NL176458C (nl)

Priority Applications (18)

Application Number Priority Date Filing Date Title
NLAANVRAGE7212915,A NL176458C (nl) 1972-09-23 1972-09-23 Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze voor de bereiding van daartoe geschikte actieve stoffen.
ZA737131*A ZA737131B (en) 1972-09-23 1973-09-06 Novel pyrimidino derivatives
IE1587/73A IE38221B1 (en) 1972-09-23 1973-09-06 Novel tetracyclic pyramidines
US396251A US3892695A (en) 1972-09-23 1973-09-07 Pyrimidino-dibenzo-azepine,-oxazepine,-thiazepine and diazepine derivatives
AU60197/73A AU472312B2 (en) 1972-09-23 1973-09-11 Novel pyrimidino derivatives
GB4331873A GB1445765A (en) 1972-09-23 1973-09-14 Phenoxy-substituted malonic acid derivatives their prepration and pharmaceutical compositions containing them
DK507673AA DK140668B (da) 1972-09-23 1973-09-17 Analogifremgangsmåde til fremstilling af kondenserede pyriminderivater.
CA181,312A CA1019733A (en) 1972-09-23 1973-09-18 Pyrimidino-dibenzo-azepine, dibenzo-oxazepine, -thiazepine and -diazepine derivatives
AR250175A AR203090A1 (es) 1972-09-23 1973-09-20 Procedimiento para la preparacion de derivados de hexahidro-pirimidino-dibenzo-azepina
FR7333768A FR2199996B1 (nl) 1972-09-23 1973-09-20
CH1358173A CH592094A5 (nl) 1972-09-23 1973-09-21
BE135926A BE805178A (fr) 1972-09-23 1973-09-21 Nouveaux derives de pyrimidine
FI2963/73A FI54311C (fi) 1972-09-23 1973-09-21 Foerfarande foer framstaellning av pyrimidinobenso-oxazepiner -tiazepiner -diazepiner och -azepiner med inverkan pao centralnervsystemet
JP48106809A JPS5912678B2 (ja) 1972-09-23 1973-09-21 新規のピリミジン誘導体の製造方法
HUAO373A HU167206B (nl) 1972-09-23 1973-09-21
DE2347727A DE2347727C2 (de) 1972-09-23 1973-09-21 Dibenzo-pyrimido-azepine, -oxazepine und- diazepine
SE7312873A SE407686B (sv) 1972-09-23 1973-09-21 Analogiforfarande for framstellning av kondenserade pyrimidinderivat
ES418996A ES418996A1 (es) 1972-09-23 1973-09-22 Un procedimiento para la preparacion de derivados de piri- midina biologicamente activos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7212915,A NL176458C (nl) 1972-09-23 1972-09-23 Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze voor de bereiding van daartoe geschikte actieve stoffen.

Publications (3)

Publication Number Publication Date
NL7212915A true NL7212915A (nl) 1974-03-26
NL176458B NL176458B (nl) 1984-11-16
NL176458C NL176458C (nl) 1985-04-16

Family

ID=19816997

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7212915,A NL176458C (nl) 1972-09-23 1972-09-23 Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze voor de bereiding van daartoe geschikte actieve stoffen.

Country Status (18)

Country Link
US (1) US3892695A (nl)
JP (1) JPS5912678B2 (nl)
AR (1) AR203090A1 (nl)
AU (1) AU472312B2 (nl)
BE (1) BE805178A (nl)
CA (1) CA1019733A (nl)
CH (1) CH592094A5 (nl)
DE (1) DE2347727C2 (nl)
DK (1) DK140668B (nl)
ES (1) ES418996A1 (nl)
FI (1) FI54311C (nl)
FR (1) FR2199996B1 (nl)
GB (1) GB1445765A (nl)
HU (1) HU167206B (nl)
IE (1) IE38221B1 (nl)
NL (1) NL176458C (nl)
SE (1) SE407686B (nl)
ZA (1) ZA737131B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.
GB1472382A (en) * 1975-01-16 1977-05-04 Wyeth John & Brother Ltd Dibenzopyrimidoazepines
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
CH678623A5 (en) * 1989-05-17 1991-10-15 Sochinaz Societe Chimique De V Prepn. of di:benzo pyrazino azepine(s)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154511B (nl) * 1967-07-07 1977-09-15 Organon Nv Werkwijze ter bereiding van piperazinederivaten, werkwijze ter bereiding van een farmaceutisch preparaat, dat een dergelijke verbinding bevat en vormstukken bereid volgens deze werkwijze.
US3470181A (en) * 1967-10-23 1969-09-30 American Home Prod Fused 2-pyrimidinepropionic acid compounds,related compounds,and the process for their preparation

Also Published As

Publication number Publication date
JPS5912678B2 (ja) 1984-03-24
CH592094A5 (nl) 1977-10-14
NL176458C (nl) 1985-04-16
IE38221B1 (en) 1978-01-18
ES418996A1 (es) 1976-07-01
US3892695A (en) 1975-07-01
DE2347727C2 (de) 1986-12-11
CA1019733A (en) 1977-10-25
SE407686B (sv) 1979-04-09
FR2199996B1 (nl) 1977-09-09
HU167206B (nl) 1975-09-27
JPS4985098A (nl) 1974-08-15
DK140668B (da) 1979-10-22
FI54311C (fi) 1978-11-10
DE2347727A1 (de) 1974-04-04
AU6019773A (en) 1975-03-13
AU472312B2 (en) 1976-05-20
AR203090A1 (es) 1975-08-14
BE805178A (fr) 1974-03-21
DK140668C (nl) 1980-03-24
IE38221L (en) 1974-03-23
FI54311B (fi) 1978-07-31
FR2199996A1 (nl) 1974-04-19
NL176458B (nl) 1984-11-16
GB1445765A (en) 1976-08-11
ZA737131B (en) 1974-08-28

Similar Documents

Publication Publication Date Title
FR2199996B1 (nl)
JPS524505Y2 (nl)
JPS5149712Y2 (nl)
JPS4993218U (nl)
JPS522981Y2 (nl)
JPS508458Y2 (nl)
JPS5253366Y2 (nl)
JPS48104352A (nl)
JPS4998056U (nl)
JPS4987506U (nl)
JPS4955763A (nl)
CH546009A (nl)
CH563257A5 (nl)
CH559436A5 (nl)
CH560400A5 (nl)
CH560461A5 (nl)
CH560310A5 (nl)
BG20618A3 (nl)
CH562066A5 (nl)
CH562125A5 (nl)
BG18475A1 (nl)
BG18468A1 (nl)
CH562369A5 (nl)
BG18463A1 (nl)
CH562536A5 (nl)

Legal Events

Date Code Title Description
BC A request for examination has been filed
A85 Still pending on 85-01-01
V1 Lapsed because of non-payment of the annual fee